1. Home
  2. SGU vs KMDA Comparison

SGU vs KMDA Comparison

Compare SGU & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SGU

Star Group L.P.

HOLD

Current Price

$12.52

Market Cap

422.1M

ML Signal

HOLD

Logo Kamada Ltd.

KMDA

Kamada Ltd.

HOLD

Current Price

$8.30

Market Cap

458.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGU
KMDA
Founded
1995
1990
Country
United States
Israel
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
422.1M
458.6M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
SGU
KMDA
Price
$12.52
$8.30
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$13.00
AVG Volume (30 Days)
27.5K
85.6K
Earning Date
02-04-2026
03-04-2026
Dividend Yield
5.85%
2.40%
EPS Growth
102.23
30.41
EPS
1.82
0.35
Revenue
$1,784,418,000.00
$174,787,000.00
Revenue This Year
N/A
$14.79
Revenue Next Year
N/A
$11.38
P/E Ratio
$6.94
$23.70
Revenue Growth
1.04
10.36
52 Week Low
$11.31
$5.54
52 Week High
$13.75
$9.16

Technical Indicators

Market Signals
Indicator
SGU
KMDA
Relative Strength Index (RSI) 63.46 59.29
Support Level $12.51 $7.85
Resistance Level $12.90 $8.88
Average True Range (ATR) 0.21 0.23
MACD 0.02 0.02
Stochastic Oscillator 64.60 53.28

Price Performance

Historical Comparison
SGU
KMDA

About SGU Star Group L.P.

Star Group LP is a home heating oil and propane distributor and services provider with one reportable operating segment that principally provides heating related services to residential and commercial customers. It serves residential and commercial customers whose primary use is to heat their homes and buildings in the Northeast and Mid-Atlantic U.S. regions. The company derives the majority of revenue from Petroleum products, which consist of home heating oil and propane as well as diesel fuel and gasoline.

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Share on Social Networks: